相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Mechanisms in Coupling of Bone Formation to Resorption
T. John Martin et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
Derliz Mereles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Metformin Stimulates Osteoprotegerin and Reduces RANKL Expression in Osteoblasts and Ovariectomized Rats
Qi-Guang Mai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Combination Therapy with Epigallocatechin-3-Gallate and Doxorubicin in Human Prostate Tumor Modeling Studies Inhibition of Metastatic Tumor Growth in Severe Combined Immunodeficiency Mice
Mark E. Stearns et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass
M. Shah et al.
BONE (2010)
AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts
Young-Sun Lee et al.
BONE (2010)
Measuring and improving adherence to osteoporosis pharmacotherapy
Suzanne M. Cadarette et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function
Julian M. W. Quinn et al.
FASEB JOURNAL (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model
Chwan-Li Shen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Epigallocatechin-3-gallate Inhibits Osteoclastogenesis by Down-Regulating c-Fos Expression and Suppressing the Nuclear Factor-kappa B Signal
Jong-Ho Lee et al.
MOLECULAR PHARMACOLOGY (2010)
Homocysteine-Lowering Therapy or Antioxidant Therapy for Bone Loss in Parkinson's Disease
Seung Hun Lee et al.
MOVEMENT DISORDERS (2010)
AMPK activators - potential therapeutics for metabolic and other diseases
G. Zhou et al.
ACTA PHYSIOLOGICA (2009)
Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression
Ippei Kanazawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats
Chwan-Li Shen et al.
BONE (2009)
Osteoblast Differentiation Is Functionally Associated With Decreased AMP Kinase Activity
Takayuki Kasai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Osteoclast-osteoblast communication
Koichi Matsuo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression
Ippei Kanazawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast
Ji-Eun Kim et al.
BONE (2008)
AMP-activated protein kinase is involved in COX-2 expression in response to ultrasound in cultured osteoblasts
Chun-Han Hou et al.
CELLULAR SIGNALLING (2008)
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase
Xiuyun Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula
Luping Qin et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Leptin and the sympathetic connection of fat to bone
M. W. Hamrick et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells
Ippei Kanazawa et al.
BMC CELL BIOLOGY (2007)
Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase
Qu Fan Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mechanisms of anabolic therapies for osteoporosis
Ernesto Canalis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Can EGCG reduce abdominal fat in obese subjects?
Alison M. Hill et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2007)
Skeletal remodeling in health and disease
Mone Zaidi
NATURE MEDICINE (2007)
Anti-obesity effects of green tea: From bedside to bench
S Wolfram et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model
ZP Liu et al.
JOURNAL OF MEDICINAL FOOD (2005)
Novel treatments for obesity and osteoporosis: Targeting apoptotic pathways in adipocytes
C Nelson-Dooley et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase
MS Kim et al.
NATURE MEDICINE (2004)
The emergence of the metabolic syndrome with menopause
MC Carr
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: Histomorphometric evidence in a longitudinal study
G Khastgir et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Modulation of endocrine systems and food intake by green tea epigallocatechin gallate
YH Kao et al.
ENDOCRINOLOGY (2000)
Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols
SB Kim et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2000)
分享论文
